Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method

European Journal of Clinical Pharmacology

Volumn 67, Issue 11, 2011, Pages 1139-1145

  Aklillu, Eleni ^a   Mugusi, Sabina ^b   Ngaimisi, Eliford ^a,c   Hoffmann, Michael Marcus ^d   König, Sonja ^e   Ziesenitz, Victoria ^e   Mikus, Gerd ^e   Haefeli, Walter Emil ^e   Weiss, Johanna ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

388A>G; 521C>T; Europeans; Hybridization probes; rs2306283; rs4149056; SLCO1B1; Tanzanians

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; THREONINE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; MARKER GENE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SLCO1B1 GENE; TANZANIA; VALIDATION PROCESS;

AFRICAN CONTINENTAL ANCESTRY GROUP; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC TESTING; GENOTYPE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; TANZANIA;

EID: 80054741154     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1065-9     Document Type: Article

References (38)

1. M Weiner C Peloquin W Burman CC Luo M Engle TJ Prihoda WR Mac Kenzie E Bliven-Sizemore JL Johnson A Vernon 2010 Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations Antimicrob Agents Chemother 54 4192 4200 20660695 10.1128/AAC.00353-10 1:CAS:528: DC%2BC3cXhtlegtr7F
2. JY Chung JY Cho KS Yu JR Kim DS Oh HR Jung KS Lim KH Moon SG Shin IJ Jang 2005 Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers Clin Pharmacol Ther 78 342 350 16198653 10.1016/j.clpt.2005.07.003 1:CAS:528:DC%2BD2MXhtVGrsb7M (Pubitemid 41393669)
3. MK Pasanen M Neuvonen PJ Neuvonen M Niemi 2006 SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid Pharmacogenet Genomics 16 873 879 17108811 10.1097/01.fpc.0000230416.82349.90 1:CAS:528: DC%2BD28Xht1SmtrvP (Pubitemid 44772805)
4. M Cvetkovic B Leake MF Fromm GR Wilkinson RB Kim 1999 OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine Drug Metab Dispos 27 866 871 10421612 1:CAS:528:DyaK1MXkvFCgt7w%3D (Pubitemid 29347585)
5. X Xiang Y Han M Neuvonen MK Pasanen A Kalliokoski JT Backman J Laitila PJ Neuvonen M Niemi 2009 Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans Pharmacogenet Genomics 19 447 457 19387419 10.1097/FPC.0b013e32832bcf7b 1:CAS:528:DC%2BD1MXmtFKhurY%3D
6. A Treiber R Schneiter S Häusler B Stieger 2007 Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil Drug Metab Dispos 35 1400 1407 17496208 10.1124/dmd.106.013615 1:CAS:528:DC%2BD2sXosVKquro%3D (Pubitemid 47121782)
7. RC Hartkoorn WS Kwan V Shallcross A Chaikan N Liptrott D Egan ES Sora CE James S Gibbons PG Bray DJ Back SH Khoo A Owen 2010 HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms Pharmacogenet Genomics 20 112 120 20051929 10.1097/FPC.0b013e328335b02d 1:CAS:528:DC%2BC3cXnvFyrsQ%3D%3D
8. C Fahrmayr MF Fromm J König 2010 Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects Drug Metab Rev 42 380 401 20100011 10.3109/03602530903491683 1:CAS:528:DC%2BC3cXotlSmt7s%3D
9. J Mwinyi K Köpke M Schaefer I Roots T Gerloff 2008 Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations Eur J Clin Pharmacol 64 257 266 18185926 10.1007/s00228-007-0409-y 1:CAS:528:DC%2BD1cXitVSit7s%3D
10. K Maeda I Ieiri K Yasuda A Fujino H Fujiwara K Otsubo M Hirano T Watanabe Y Kitamura H Kusuhara Y Sugiyama 2006 Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril Clin Pharmacol Ther 79 427 439 16678545 10.1016/j.clpt.2006.01.011 1:CAS:528:DC%2BD28XktVegsLk%3D
11. S Oswald J König D Lütjohann T Giessmann HK Kroemer C Rimmbach D Rosskopf MF Fromm W Siegmund 2008 Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1 Pharmacogenet Genomics 18 559 568 18551036 10.1097/FPC.0b013e3282fe9a2c 1:CAS:528:DC%2BD1cXntFWmsrk%3D
12. GA Kullak-Ublick B Stieger PJ Meier 2004 Enterohepatic bile salt transporters in normal physiology and liver disease Gastroenterology 126 322 342 14699511 10.1053/j.gastro.2003.06.005 1:CAS:528:DC%2BD2cXhtFGnur0%3D (Pubitemid 38040747)
13. Y Nishizato I Ieiri H Suzuki M Kimura K Kawabata T Hirota H Takane S Irie H Kusuhara Y Urasaki A Urae S Higuchi K Otsubo Y Sugiyama 2003 Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics Clin Pharmacol Ther 73 554 565 12811365 10.1016/S0009-9236(03) 00060-2 1:CAS:528:DC%2BD3sXkt1Ortbg%3D (Pubitemid 37249126)
14. RG Tirona BF Leake AW Wolkoff RB Kim 2003 Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation J Pharmacol Exp Ther 304 223 228 12490595 10.1124/jpet.102.043026 1:CAS:528:DC%2BD3sXht1Shtg%3D%3D (Pubitemid 36008932)
15. M Niemi E Schaeffeler T Lang MF Fromm M Neuvonen C Kyrklund JT Backman R Kerb M Schwab PJ Neuvonen M Eichelbaum KT Kivistö 2004 High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1) Pharmacogenetics 14 429 440 15226675 10.1097/01.fpc.0000114750.08559.32 1:CAS:528:DC%2BD2cXlt1Cktrk%3D (Pubitemid 38971233)
16. M Niemi MK Pasanen PJ Neuvonen 2006 SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin Clin Pharmacol Ther 80 356 366 17015053 10.1016/j.clpt.2006.06.010 1:CAS:528:DC%2BD28XhtVWqurjN (Pubitemid 44465886)
17. RH Ho L Choi W Lee G Mayo UI Schwarz RG Tirona DG Bailey C Michael Stein RB Kim 2007 Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants Pharmacogenet Genomics 17 647 656 17622941 10.1097/FPC.0b013e3280ef698f 1:CAS:528:DC%2BD2sXnsFOjs7s%3D (Pubitemid 47057714)
18. I Ieiri S Suwannakul K Maeda H Uchimaru K Hashimoto M Kimura H Fujino M Hirano H Kusuhara S Irie S Higuchi Y Sugiyama 2007 SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers Clin Pharmacol Ther 82 541 547 17460607 10.1038/sj.clpt.6100190 1:CAS:528:DC%2BD2sXhtF2qsL7I (Pubitemid 47622520)
19. JH Choi MG Lee JY Cho JE Lee KH Kim K Park 2008 Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans Clin Pharmacol Ther 83 251 257 17568401 10.1038/sj.clpt.6100267 1:CAS:528:DC%2BD1cXitFKjtLY%3D (Pubitemid 351147710)
20. MK Pasanen H Fredrikson PJ Neuvonen M Niemi 2007 Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin Clin Pharmacol Ther 82 726 733 17473846 10.1038/sj.clpt.6100220 1:CAS:528:DC%2BD2sXht1ymu7jM (Pubitemid 350114817)
21. M Niemi KT Kivistö U Hofmann M Schwab M Eichelbaum MF Fromm 2005 Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1) Br J Clin Pharmacol 59 602 604 15842561 10.1111/j.1365-2125.2005.02354.x 1:CAS:528:DC%2BD2MXltFGgt7Y%3D (Pubitemid 40632253)
22. JY Han HS Lim ES Shin YK Yoo YH Park JE Lee HT Kim JS Lee 2008 Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer Lung Cancer 59 69 75 17766002 10.1016/j.lungcan.2007. 07.019
23. A Kalliokoski M Neuvonen PJ Neuvonen M Niemi 2008 Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide J Clin Pharmacol 48 311 321 18187595 10.1177/0091270007311569 1:CAS:528:DC%2BD1cXjs1ekt7k%3D (Pubitemid 351257770)
24. FB Kohlrausch ER de Cássia PF Barroso G Suarez-Kurtz 2010 The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men Br J Clin Pharmacol 69 95 98 20078617 10.1111/j.1365-2125.2009.03551.x 1:CAS:528:DC%2BC3cXhvFSltbk%3D
25. RA Op den Buijsch PA Wijnen MP van Dieijen-Visser JE de Vries O Bekers 2005 Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays Pharmacogenomics 6 393 397 16004557 10.1517/14622416.6.4.393 1:CAS:528:DC%2BD2MXmvVaqtr4%3D (Pubitemid 40916362)
26. EY Kim DY Cho HJ Shin SS Lee JH Shon JG Shin SG Shin 2008 Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations Clin Chim Acta 388 68 72 17996736 10.1016/j.cca.2007.10. 010 1:CAS:528:DC%2BD2sXhsVOltLfM (Pubitemid 350266571)
27. RG Tirona BF Leake G Merino RB Kim 2001 Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans J Biol Chem 276 35669 35675 11477075 10.1074/jbc.M103792200 1:CAS:528:DC%2BD3MXntFahsb4%3D
28. M Rohrbacher A Kirchhof C Skarke G Geisslinger J Lötsch 2006 Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing Pharmacogenomics 7 167 176 16515396 10.2217/14622416.7.2.167 1:CAS:528:DC%2BD28XlsFGjt7Y%3D
29. MK Pasanen JT Backman PJ Neuvonen M Niemi 2006 Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population Eur J Clin Pharmacol 62 409 415 16758257 10.1007/s00228-006-0123-1 1:CAS:528:DC%2BD28XltlOjur8%3D (Pubitemid 43873712)
30. SR Jada S Xiaochen LY Yan X Xiaoqiang S Lal SF Zhou LL Ooi B Chowbay 2007 Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations Eur J Clin Pharmacol 63 555 563 17415554 10.1007/s00228-007-0285-5 1:CAS:528:DC%2BD2sXkslWns7g%3D (Pubitemid 46684484)
31. X Xiang SR Jada HH Li L Fan LS Tham CI Wong SC Lee R Lim QY Zhou BC Goh EH Tan B Chowbay 2006 Pharmacogenetics of SLCO1B1 gene and the impact of *1b and*15 haplotypes on irinotecan disposition in Asian cancer patients Pharmacogenet Genomics 16 683 691 16906022 10.1097/01.fpc.0000230420. 05221.71 1:CAS:528:DC%2BD28XotVWksLk%3D (Pubitemid 44223079)
32. E Ngaimisi S Mugusi OM Minzi P Sasi KD Riedel A Suda N Ueda M Janabi F Mugusi WE Haefeli J Burhenne E Aklillu 2010 Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients Clin Pharmacol Ther 88 676 684 20881953 10.1038/clpt.2010.172 1:CAS:528:DC%2BC3cXhtlWmurjI
33. JK Mukonzo D Röshammar P Waako M Andersson T Fukasawa L Milani JO Svensson J Ogwal-Okeng LL Gustafsson E Aklillu 2009 A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans Br J Clin Pharmacol 68 690 699 19916993 10.1111/j.1365-2125.2009.03516.x 1:CAS:528:DC%2BD1MXhsFKrsrrN
34. W Zhang YJ He Z Gan L Fan Q Li A Wang ZQ Liu S Deng YF Huang LY Xu HH Zhou 2007 ATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation Clin Exp Pharmacol Physiol 34 1240 1244 17973861 10.1111/j.1440-1681.2007.04798.x 1:CAS:528:DC%2BD2sXhtlWmtLrK (Pubitemid 350013247)
35. J Mwinyi A Johne S Bauer I Roots T Gerloff 2003 Evidence for inverse effects of OATP-C (SLC21A6)*5 and*1b haplotypes on pravastatin kinetics Clin Pharmacol Ther 75 415 421 10.1016/j.clpt.2003.12.016 (Pubitemid 38534562)
36. M Niemi MK Pasanen PJ Neuvonen 2011 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake Pharmacol Rev 63 157 181 21245207 10.1124/pr.110.002857 1:CAS:528:DC%2BC3MXjslGis7w%3D
37. GD Vladutiu PJ Isackson 2009 SLCO1B1 variants and statin-induced myopathy N Engl J Med 360 304 19144951 10.1056/NEJMc081975 1:CAS:528: DC%2BD1MXnslWjtg%3D%3D
38. MK Pasanen PJ Neuvonen M Niemi 2008 Global analysis of genetic variation in SLCO1B1 Pharmacogenomics 9 19 33 18154446 10.2217/14622416.9.1.19 1:CAS:528:DC%2BD1cXhtFOjsw%3D%3D (Pubitemid 351560529)